Cdk2-dependent Phosphorylation of the NF-Y Transcription Factor and Its Involvement in the p53-p21 Signaling Pathway

Jeanho Yun, Hee‐Don Chae, Taesaeng Choi, Eun Hee Kim, Yung‐Jue Bang, Jongkyeong Chung, Kyeong Sook Choi, Roberto Mantovani, Deug Y. Shin

Journal of Biological Chemistry · 2003 · 83 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

Recent studies have suggested that the NF-Y transcription factor is involved in transcription repression of the cell cycle regulatory genes in a response to p53 induction or DNA damage. Here we demonstrate the cdk2-dependent phosphorylation of NF-Y and its involvement in transcription repression by the p53-p21 signaling pathway. Cdk2 phosphorylates two serine residues near the DNA-binding domain of the YA subunit of NF-Y. Cyclin A-cdk2 appears to associate with NF-Y both in vitro and in vivo. Furthermore, YA protein is phosphorylated in parallel with a cell cycle-dependent activation of cdk2 kinase and cyclin A expression. YA phosphorylation is unnecessary for heterotrimer formation with the YB-YC dimer. However, NF-Y containing a phosphorylation-deficient mutant form of YA, YA-aa, has its DNA binding activity impaired. Consistently, YA-aa inhibits transcription activation of a NF-Y target promoter, cdc2, by cdk2. These results facilitate the elucidation of the regulatory mechanisms of cell cycle progression involving the p21-cdk2-NF-Y signaling pathway. Recent studies have suggested that the NF-Y transcription factor is involved in transcription repression of the cell cycle regulatory genes in a response to p53 induction or DNA damage. Here we demonstrate the cdk2-dependent phosphorylation of NF-Y and its involvement in transcription repression by the p53-p21 signaling pathway. Cdk2 phosphorylates two serine residues near the DNA-binding domain of the YA subunit of NF-Y. Cyclin A-cdk2 appears to associate with NF-Y both in vitro and in vivo. Furthermore, YA protein is phosphorylated in parallel with a cell cycle-dependent activation of cdk2 kinase and cyclin A expression. YA phosphorylation is unnecessary for heterotrimer formation with the YB-YC dimer. However, NF-Y containing a phosphorylation-deficient mutant form of YA, YA-aa, has its DNA binding activity impaired. Consistently, YA-aa inhibits transcription activation of a NF-Y target promoter, cdc2, by cdk2. These results facilitate the elucidation of the regulatory mechanisms of cell cycle progression involving the p21-cdk2-NF-Y signaling pathway. Sequential activation and inactivation of cyclin-dependent kinases (CDKs) 1The abbreviations used are: CDK, cyclin-dependent kinase; GST, glutathione S-transferase; pcdc2-luc, cdc2 promoter-luciferase. ensure an orderly progress through the cell cycle (1Morgan D.O. Nature. 1995; 374: 131-134Crossref PubMed Scopus (2938) Google Scholar). CDK activities are regulated by a variety of mechanisms, such as a periodic cyclin accumulation and degradation, nuclear localization, phosphorylation of CDKs, and association with a number of different CDK inhibitors (2Morgan D.O. Annu. Rev. Cell Dev. Biol. 1997; 13: 261-291Crossref PubMed Scopus (1810) Google Scholar, 3Sherr C.J. Science. 1996; 274: 1672-1677Crossref PubMed Scopus (4986) Google Scholar, 4Nasmyth K. Science. 1996; 274: 1643-1645Crossref PubMed Scopus (325) Google Scholar). The cyclin-CDK complexes are thought to control the cell cycle by phosphorylating key regulatory proteins at specific points of the cell cycle. There is therefore a great deal of interest in identifying specific substrates for these cyclin-CDK complexes at each cell cycle phase. NF-Y, also known as CBF (CCAAT-binding factor), was first identified as a protein that binds to the Y box of MHC (major histocompatibility complex) class II Eα promoters (5Dorn A. Bollekens J. Staub A. Benoist C. Mathis D. Cell. 1987; 50: 863-872Abstract Full Text PDF PubMed Scopus (474) Google Scholar). Unlike other CCAAT-binding proteins, NF-Y has an absolute requirement for the CCAAT pentanucleotide as well as a strong preference for specific flanking sequences (5Dorn A. Bollekens J. Staub A. Benoist C. Mathis D. Cell. 1987; 50: 863-872Abstract Full Text PDF PubMed Scopus (474) Google Scholar). Unique among transcription factors, NF-Y is comprised of three different subunits, YA, YB, and YC, which are collectively required to bind the CCAAT motif (6Sinha S. Kim I.S. Sohn K.Y. de Crombrugghe B. Maity S.N. Mol. Cell. Biol. 1996; 16: 328-337Crossref PubMed Scopus (145) Google Scholar). Biochemical analysis showed that YB and YC interact with each other to form a stable heterodimer and that YA only interacts with the YB-YC heterodimer to form a heterotrimeric NF-Y (6Sinha S. Kim I.S. Sohn K.Y. de Crombrugghe B. Maity S.N. Mol. Cell. Biol. 1996; 16: 328-337Crossref PubMed Scopus (145) Google Scholar). The YB and YC subunits associate through an evolutionarily well conserved domain that contains the histone-fold “hand shake” motif, which resembles the α-helical structure in histone H2B/H2A (7Baxevanis A.D. Arents G. Moudrianakis E.N. Landsman D. Nucleic Acids Res. 1995; 23: 2685-2691Crossref PubMed Scopus (181) Google Scholar). The N-terminal half of YA contains a glutamine-rich domain (8Li X.Y. Hooft van Huijsduijnen R. Mantovani R. Benoist C. Mathis D. J. Biol. Chem. 1992; 267: 8984-8990Abstract Full Text PDF PubMed Google Scholar); the C-terminal half is essential for DNA binding and interaction with the YB-YC heterodimer (9Maity S.N. de Crombrugghe B. Trends Biochem. Sci. 1998; 23: 174-178Abstract Full Text Full Text PDF PubMed Scopus (312) Google Scholar). Initial studies led to the identification of NF-Y in almost all cell types, suggesting that it represents a prototypic example of an immutable, constitutive transcription factor. However, several later reports demonstrated that the DNA binding activity of NF-Y changes during different stages of B-cell development (10Currie R.A. J. Biol. Chem. 1998; 273: 18220-18229Abstract Full Text Full Text PDF PubMed Scopus (17) Google Scholar), senescence (11Pang J.H. Chen K.Y. J. Biol. Chem. 1993; 268: 2909-2916Abstract Full Text PDF PubMed Google Scholar, 12Jung M.S. Yun J. Chae H.D. Kim J.M. Kim S.C. Choi T.S. Shin D.Y. Oncogene. 2001; 20: 5818-5825Crossref PubMed Scopus (79) Google Scholar), and differentiation (13Marziali G. Perrotti E. Ilari R. Testa U. Coccia E.M. Battistini A. Mol. Cell. Biol. 1997; 17: 1387-1395Crossref PubMed Scopus (83) Google Scholar, 14Marziali G. Perrotti E. Ilari R. Coccia E.M. Mantovani R. Testa U. Battistini A. Blood. 1999; 93: 519-526Crossref PubMed Google Scholar, 15Farina A. Manni I. Fontemaggi G. Tiainen M. Cenciarelli C. Bellorini M. Mantovani R. Sacchi A. Piaggio G. Oncogene. 1999; 18: 2818-2827Crossref PubMed Scopus (96) Google Scholar). With regard to the cell cycle, it has been shown that NF-Y binds to and activates the promoters of G1/S genes, a family of genes whose expression is induced at G1/S. These G1/S genes can be further subdivided into two different groups, S- and G2-specific genes, depending on the cell cycle phases at which they are needed. G2-specific genes, whose expression is induced at G1/S and reaches maximum levels at G2/M phase, such as cdc2, cyclin B, and cdc25C, play a key role at G2/M transition (1Morgan D.O. Nature. 1995; 374: 131-134Crossref PubMed Scopus (2938) Google Scholar, 16Zwicker J. Lucibello F.C. Wolfraim L.A. Gross C. Truss M. Engeland K. Muller R. EMBO J. 1995; 14: 4514-4522Crossref PubMed Scopus (281) Google Scholar). We previously found that p53 inhibits cell cycle-dependent transcription of cell cycle regulatory genes, such as cdc2 and cyclin B genes, which, in turn, results in inactivation of cdc2 and G2 checkpoint arrest (17Park M. Chae H.D. Yun J. Jung M. Kim Y.S. Kim S.H. Han M.H. Shin D.Y. Cancer Res. 2000; 60: 542-545PubMed Google Scholar). Also, NF-Y is involved in transcription repression of G2-specific genes after p53 induction and DNA damage (18Yun J. Chae H.D. Choy H.E. Chung J. Yoo H.S. Han M.H. Shin D.Y. J. Biol. Chem. 1999; 274: 29677-29682Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar, 19Manni J. Mazzaro G. Gurtner A. Mantovani R. Haugwitz U. Krause K. Engeland K. Sacchi A. Soddu S. Piaggio G. J. Biol. Chem. 2001; 276: 5570-5576Abstract Full Text Full Text PDF PubMed Scopus (150) Google Scholar). Furthermore, the DNA binding activity of NF-Y is decreased by p53 (12Jung M.S. Yun J. Chae H.D. Kim J.M. Kim S.C. Choi T.S. Shin D.Y. Oncogene. 2001; 20: 5818-5825Crossref PubMed Scopus (79) Google Scholar). These studies suggested a possibility that inhibition of cdk2 by p21 is involved in the repression of DNA binding activity of NF-Y by p53 and led us to investigate a mechanism for regulation of NF-Y by cdk2-dependent phosphorylation. Cell Culture and Transfection—Human HEK293, EJ, and HCT116 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. DNA transfections were performed using the CaPO4 coprecipitation procedure (20Graham F.L. van der Eb A.J. Virology. 1973; 54: 536-539Crossref PubMed Scopus (419) Google Scholar). We differentially used three independent cell lines: HEK293 for transient expression of target genes, EJ for stable expression, and HCT116 for cell cycle analysis. In transient transfection experiments, pCMV-β-galactosidase plasmid was used to monitor and to normalize the transfection efficiency (18Yun J. Chae H.D. Choy H.E. Chung J. Yoo H.S. Han M.H. Shin D.Y. J. Biol. Chem. 1999; 274: 29677-29682Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar). Construction of Expression Plasmids and Recombinant Adenovirus—To generate FLAG epitope-tagged NF-Y expression plasmids, we cloned the coding sequences of YA, YB, and YC from Δ4YA13, Δ4YB, and Δ4YC (21Mantovani R. Li X.Y. Pessara U. Hooft van Huisjduijnen R. Benoist C. Mathis D. J. Biol. Chem. 1994; 269: 20340-20346Abstract Full Text PDF PubMed Google Scholar), respectively, into the pFLAG-CMV2 vector (Sigma). Point mutations at phosphorylation sites were generated using the overlapping extension PCR method (22Dieffenbach C.W. Dveksler G.S. Dieftenbach C. PCR Primer: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Woodbury, NY1995Google Scholar). All substitutions were verified by DNA sequencing. The DNA fragments obtained by PCR were cloned into the pFLAG-CMV2 vector, resulting in plasmids pFLAG-YA-aa, pFLAG-YA-as, and pFLAG-YA-sa. Cloning of wild type and mutant YA into pGEX-KG generated pGST-YA, -YA-aa, -YA-as, and -YA-sa constructs. Electrophoretic Mobility Shift Assay—Nuclear lysates were prepared and NF-Y binding reactions were performed as described earlier (18Yun J. Chae H.D. Choy H.E. Chung J. Yoo H.S. Han M.H. Shin D.Y. J. Biol. Chem. 1999; 274: 29677-29682Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar). Briefly, nuclear lysates (5 μg) were incubated with an end-labeled DNA probe containing the distal CCAAT motif of the cdc2 promoter (-88 to -64). The resulting DNA-protein complexes were separated on a 6% polyacrylamide gel in 0.25 × TBE at 15 mA for 2 h. For antibody supershift assay, 1 μg of anti-NF-YA antibody (Accurate) or an anti-FLAG antibody (M2; Sigma) was added into the preincubation mixture. The radioactivity of the desired band was measured, using a phosphorimaging analyzer (Fuji). Immunoprecipitation and Western Blot Analyses—Cell extracts were prepared using RIPA buffer and then subjected to Western blotting and immunoprecipitation (23Park S.P. Kim E.J. Park T.C. Kim E.J. Kim J. Lee J.M. Namgoong S.E. Um S.J. Cancer Res. Treat. 2001; 33: 236-242Crossref PubMed Google Scholar). The immunoprecipitated mixture or 20 μg of total protein was separated on a 12% SDS gel and transferred to a polyvinylidene difluoride membrane (PerkinElmer Life Sciences). Mouse and rabbit antibodies for immunoprecipitation used are as follows: anti-FLAG (M2; Sigma-Aldrich), anti-cdk2 (SC-163; Santa Cruz Biotechnology Inc., Santa Cruz, CA), anti-cdc2 (SC-54), anti-cdk4 (SC-260), anti-cyclin A (SC-596), anti-cyclin B (SC-752), and anti-cyclin E (AB-1; Neomarkers, Fremont, CA) antibodies. Antibodies against each subunit of NF-Y (YA, SC-7712; YB, SC-7711; YC, SC-7715; Santa Cruz Biotechnology Inc.), cyclin A (SC-596; Santa Cruz Biotechnology Inc.), and cyclin E (AB-1; Neomarkers) were used for Western blotting of immunoprecipitates. GST Pull-down Experiments—Cells were prepared using lysis buffer (20 mm Tris-HCl (pH 7.2), 150 mm NaCl, 1 mm CaCl2, 0.3% Triton X-100, 1 mm phenylmethylsulfonyl fluoride, 100 mm benzamidine). The lysates were precleared by incubation with glutathione-Sepharose 4B beads for 1 h at 4 °C. The precleared lysates were added to the GST-YA proteins immobilized on glutathione-Sepharose 4B beads and incubated for 1 h at 4 °C. After washing five times with lysis buffer, bound proteins were eluted, subjected to SDS-PAGE, and transferred to a polyvinylidene difluoride membrane (PerkinElmer Life Sciences). In vivo Phosphorylation Analysis—Cells were washed twice with TBS (15 mm mm in of Dulbecco's modified Eagle's fetal bovine containing of The cells were with 1 of lysis buffer mm 100 mm NaCl, 1 mm 1 1 1 and mm phenylmethylsulfonyl and to lysates were immunoprecipitated with the anti-FLAG antibody and protein After were and a 12% gel for protein were by In vitro activities of complexes were by into For immunoprecipitation kinase assay, cells were washed with and in RIPA buffer mm mm NaCl, 1 Triton X-100, 1 1 1 mm phenylmethylsulfonyl mm μg) were incubated for h at 4 with 2 μg of anti-cdk2 (SC-163; Santa anti-cdc2 Santa or anti-cdk4 Santa The were immobilized on protein beads by incubation for 4 h at 4 °C. were washed twice with 1 of RIPA buffer and twice with kinase buffer mm mm 1 mm for cdk2 and cdc2 mm mm mm 1 mm for the the complexes were in of the kinase buffer containing 20 of and 2 μg of histone for the cdk2 and cdc2 and C-terminal for the The reactions were to for at °C. proteins were separated on a 12% gel and by In vitro Phosphorylation of in vitro kinase was using GST-YA protein as The cdk2 was obtained by immunoprecipitation of HEK293 or EJ cell lysates with antibodies against and CDKs, as described GST or protein μg) were incubated with the immunoprecipitated cdk2 in of kinase buffer containing 20 and of After at the was by the of SDS buffer and separated on a 10% The gel was with to and to for Phosphorylation of the YA in the NF-Y in the that p53 inhibits DNA binding activity of NF-Y through the we the possibility that CDK phosphorylates NF-Y. HEK293 cells were with each of the NF-Y subunits, YA, YB, and YC, in with the FLAG cells were with two subunits, YA and YB, were as in vivo further these subunits are phosphorylated by CDKs, we EJ cells or with a of cdc2 and a for S. M. Kim S.H. J. Biochem. 1997; PubMed Scopus Google Scholar, A. M. J. Biochem. 1997; PubMed Scopus Google Scholar). Phosphorylation of YA was by that of YB We the of p21 to phosphorylation of NF-Y. p21 is a target of p53 and has been shown to be of the of cell cycle arrest by binding of cyclin-CDK complexes C.W. D.O. Nature. 1993; PubMed Scopus Google Scholar, K. S.J. Cell. 1993; Full Text PDF PubMed Scopus Google Scholar, D. R. D. Nature. 1993; PubMed Scopus Google Scholar). were with a the p21 showed that YB phosphorylation the phosphorylation of YA was p21 expression YA is to be the only NF-Y subunit that phosphorylated by in vivo. Cell Phosphorylation of for YA phosphorylation by CDKs, we YA is phosphorylated in a cell cycle-dependent activation of is cell cells were at by After cells through the and G2 phases Cyclin B, and E respectively, induced from and h after These results with studies in which cyclin and B are in G1/S and and G2 phase, A.J. J.M. Cell Mol. Life Sci. PubMed Scopus Google Scholar). Cdk2 activity was from h and at h after cells the the protein of YA was YA phosphorylation was cell YA phosphorylated from h after YA protein is phosphorylated in parallel with a periodic activation of cdk2 kinase and cyclin A expression. Cdk2 and with We of of cdc2, and HEK293 cells were with a plasmid and a mutant of cdc2 cdk2 or S. E. Science. 1993; PubMed Scopus Google Scholar). YA phosphorylation decreased in cells the cdk2 in the cdc2 or the mutant the that cdk2 is for YA phosphorylation in vivo. that cdk2 phosphorylates YA, we performed an in vitro kinase using YA with anti-cyclin and anti-cyclin E antibodies phosphorylated GST-YA that with an anti-cyclin B antibody both cdk2 complexes YA protein in vitro YA phosphorylation cyclin A expression the cell cycle on we which of the cdk2 complexes with NF-Y. GST-YA proteins were with of EJ cells in GST binding The YA protein was found to bind cyclin A and cyclin E We further cdk2 and each subunit of NF-Y, using cell extracts from EJ cells to YA, and Western blotting analysis showed that the anti-cdk2 antibody immunoprecipitated YA and YC and proteins an anti-FLAG antibody was shown to cdk2 and cyclin cyclin E These results further for in vivo association of cyclin A-cdk2 with NF-Y. Phosphorylation of near the DNA-binding of we identified two phosphorylation sites near the DNA-binding domain residues cdk2 phosphorylates the two serine residues at and in YA, we or both with by In a kinase using GST proteins in cdk2 phosphorylated the wild type and both of the proteins and the protein of the phosphorylation of wild type and mutant YA in vivo that both of the were the protein in the form these we that cdk2 phosphorylates both of the serine residues in YA in vivo. of YA Phosphorylation in the DNA of the role of the cdk2-dependent phosphorylation of that both wild type YA and its phosphorylation-deficient mutant with the YB and YC proteins to a that phosphorylation of YA is unnecessary for its interaction with the YB-YC However, a gel demonstrated that NF-Y containing YA-aa has its DNA binding activity The of the in cells with the vector control and wild type YA was that an of YA protein the DNA binding activity of NF-Y. These results also that the YB-YC is a factor for the formation of the NF-Y A supershift showed that the with YA is at that with YA In of protein showed that total YA protein was by transfection with the YA protein with YA with to the YB-YC dimer. However, the decreased in cells with YA-aa, 12% of in cells with wild type YA NF-Y with YA was at levels in cells with wild type YA and YA-aa, with YA-aa decreased as with with wild type YA These results that the NF-Y containing YA-aa has a in DNA binding YA and YA-aa to bind the YB-YC heterodimer with that YA phosphorylation is for DNA binding activity of NF-Y, we the of cdk2 inhibitors in the DNA binding activity of NF-Y. that the DNA binding activity of NF-Y decreased as cdk2 was in cells p21 or with These results the of that p53 the DNA binding activity of NF-Y the protein levels of the three subunits of NF-Y A. Manni I. Fontemaggi G. Tiainen M. Cenciarelli C. Bellorini M. Mantovani R. Sacchi A. Piaggio G. Oncogene. 1999; 18: 2818-2827Crossref PubMed Scopus (96) Google Scholar). YA Phosphorylation for performed a transient transfection to that cdk2-dependent YA phosphorylation is required for transcription of the NF-Y target cdk2 activates the NF-Y target we the cdc2 with a cyclin A expression that cyclin A the cdc2 promoter, the mutant promoter with the CCAAT box that NF-Y is for cdk2-dependent activation of the cdc2 can be by p21 expression We YA phosphorylation is required for cdk2-dependent activation of the cdc2 showed that YA-aa the activation of the cdc2 promoter by cyclin A expression in a that YA phosphorylation is essential for cdk2-dependent cdc2 These results that YA-aa phosphorylation is for transcription activation of the NF-Y target promoters by cdk2. We further the of YA-aa can be by wild type YA-aa the cdc2 promoter, wild type YA These results with However, repression of the cdc2 promoter by YA-aa was by of wild type YA that YA-aa the cdc2 promoter by wild type YA In we have a of that the YA subunit of the NF-Y transcription factor is a of cyclin YA phosphorylation is by cell cycle phases and decreased by p21 expression and both cyclin and cdk2 as a phosphorylation in the of cyclin E and A has been demonstrated by in vivo cdk2 complexes and substrates I. J.M. J. Biol. Chem. 1999; 274: Full Text Full Text PDF PubMed Scopus Google Scholar, Oncogene. 1998; 17: PubMed Scopus Google Scholar, de J. M. EMBO J. 2001; 20: PubMed Scopus Google Scholar). We showed that cyclin A-cdk2 with NF-Y both in vitro and in vivo Furthermore, YA phosphorylation is parallel with a periodic cyclin A expression YA phosphorylation on heterotrimer formation with the YB-YC it is for DNA binding of NF-Y These results are with the of the two phosphorylated residues near the DNA binding domain of YA The role of YA phosphorylation was further by the that DNA binding activity of NF-Y decreased as cdk2 was in cells p21 and with NF-Y of three different subunits that are all required to bind DNA and YA-aa with YA with to the YB-YC YA-aa NF-Y in a A transient transfection further the of YA-aa the showed that YA phosphorylation is essential for cdk2-dependent transcription activation of the cdc2 promoter has been that the also transcription of a of NF-Y target genes, cdc2 (9Maity S.N. de Crombrugghe B. Trends Biochem. Sci. 1998; 23: 174-178Abstract Full Text Full Text PDF PubMed Scopus (312) Google Scholar, 16Zwicker J. Lucibello F.C. Wolfraim L.A. Gross C. Truss M. Engeland K. Muller R. EMBO J. 1995; 14: 4514-4522Crossref PubMed Scopus (281) Google Scholar). The cdc2 promoter contains both the NF-Y binding and binding at from the transcription J. Lucibello F.C. Wolfraim L.A. Gross C. Truss M. Engeland K. Muller R. EMBO J. 1995; 14: 4514-4522Crossref PubMed Scopus (281) Google Scholar). it has been that of the results in activity of the cdc2 promoter S. Mol. Cell. Biol. 1995; PubMed Scopus Google Scholar), we previously that the cdc2 promoter with of be further by of p53 (18Yun J. Chae H.D. Choy H.E. Chung J. Yoo H.S. Han M.H. Shin D.Y. J. Biol. Chem. 1999; 274: 29677-29682Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar), that the is the only to transcription of the cdk2 phosphorylates protein and the of it is to the CCAAT box is required for cdk2-dependent transcription showed that of cyclin A to the mutant cdc2 promoter with CCAAT box with it can be that transcription of genes be regulated by at two different signaling repression by the and activation by NF-Y. Recent reports suggested that the repression of p53 is in and cell cycle arrest Sci. U. S. A. 1994; PubMed Scopus Google Scholar, E. Mol. Cell Biol. 1995; PubMed Google Scholar, S. C. G. D. Dev. 1995; PubMed Scopus Google Scholar). repression by p53 was thought to be by of p53 with the protein or factors, resulting in inhibition of transcription A. Chen J. A.J. R. Mol. Cell Biol. 1995; PubMed Scopus Google Scholar, E. A. J. R. A.J. Sci. U. S. A. 1992; PubMed Scopus Google Scholar). However, a number of that the repression of genes is on the of binding sites of specific transcription factors, for which mechanisms are to be We previously that the transcription activation domain of p53 is essential for its to the cdc2 promoter (18Yun J. Chae H.D. Choy H.E. Chung J. Yoo H.S. Han M.H. Shin D.Y. J. Biol. Chem. 1999; 274: 29677-29682Abstract Full Text Full Text PDF PubMed Scopus (144) Google Scholar). these and results we that p21 expression by p53 to NF-Y inactivation through inhibition of cdk2-dependent phosphorylation of the YA Recent studies us that the DNA binding activity of NF-Y is in and that NF-Y target genes are only during cell cycle arrest also at the of differentiation and senescence A. Manni I. Fontemaggi G. Tiainen M. Cenciarelli C. Bellorini M. Mantovani R. Sacchi A. Piaggio G. Oncogene. 1999; 18: 2818-2827Crossref PubMed Scopus (96) Google Scholar). the CCAAT motif, which is specific for NF-Y, is in the promoters of and cell genes (9Maity S.N. de Crombrugghe B. Trends Biochem. Sci. 1998; 23: 174-178Abstract Full Text Full Text PDF PubMed Scopus (312) Google Scholar, R. Nucleic Acids Res. 1998; PubMed Scopus Google Scholar), we that the cdk2-dependent phosphorylation of NF-Y is a mechanism for transcription regulation of of cell genes in response to regulatory We E for the mutant of and K. for of the

References

31